Rapid platelet count improvement in chronic hepatitis C patients with thrombocytopenia receiving direct-acting antiviral agents

The effect of direct-acting antiviral agents (DAAs) on short-term platelet improvement in chronic hepatitis C (CHC) patients with thrombocytopenia is unclear. From December 2015 to March 2018, a total of 249 CHC patients receiving DAA treatment with baseline thrombocytopenia (platelet count <150 ...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yen-Chun, Tseng, Chih-Wei, Tseng, Kuo-Chih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220127/
https://www.ncbi.nlm.nih.gov/pubmed/32384505
http://dx.doi.org/10.1097/MD.0000000000020156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220127/
https://www.ncbi.nlm.nih.gov/pubmed/32384505
http://dx.doi.org/10.1097/MD.0000000000020156

Ejemplares similares